Nigelladine A among Selected Compounds from <i>Nigella sativa</i> Exhibits Propitious Interaction with Omicron Variant of SARS-CoV-2: An In Silico Study

<div>The bioavailability radar of Nigelladine A retrieved from SwissADME. The colored zone is the suitable physicochemical space for oral bioavailability. LIPO (lipophilicity): −0.7 &lt; XLOGP3 &lt; +5.0; SIZE: 150 g/mol &lt; MV &lt; 500 g/mol; POLAR (polarity): 20 Å<sup>2</sup> &lt; TPSA &lt; 130 Å<sup>2</sup>; INSOLU (insolubility): −6 &lt; Log S (ESOL) &lt; 0; INSATU (insaturation): 0.25 &lt; Fraction Csp3 &lt; 1; FLEX (flexibility): 0 &lt; num. rotatable bonds &lt; 9.</div>

International Journal of Clinical Practice

fig3

Figure 3

Figure 3: Nigelladine A among Selected Compounds from <i>Nigella sativa</i> Exhibits Propitious Interaction with Omicron Variant of SARS-CoV-2: An In Silico Study 

Figure 3 | Nigelladine A among Selected Compounds from Nigella sativa Exhibits Propitious Interaction with Omicron Variant of SARS-CoV-2: An In Silico Study 